The counterfeit drug ring would repackage bogus HIV medications and sell them to pharmacies, who then distributed them to patients.
The FDA has approved bimonthly PrEP injections, replacing daily pill regimens
The FDA has granted ViiV Healthcare priority review for cabotegravir, a new, injectable form of PrEP administered every two months.
London sexual health clinic 56 Dean Street noted the impact of combining treatment and prevention methods in reducing new HIV infections
Department of Labor guidance instructs insurers to remove all costs associated with PrEP, including lab tests and clinic visits
Merck said results of a study into islatravir suggested it could be used to prevent and treat HIV
Bimonthly injections were previously found to be more effective than daily pills at preventing HIV transmission
Public Health England attributed the record low to increased testing, condom usage, and the availability of PrEP
The man is in long-term HIV remission after a new drug combination, but scientists urge caution over results
GlaxoSmithKline stopped clinical trials of the PrEP drug early due to its efficacy at preventing new HIV transmissions
Three ongoing HIV vaccine trials offer reason to be hopeful, researchers say
Openly gay politician received praise for urging people to take charge of their sexual health
New South Wales reported the lowest number of new infections since records began
Maryland lawmakers have approved a bill allowing minors to receive pre-exposure prophylaxis, or PrEP, without obtaining parental consent as a way to prevent the spread...
San Francisco man was exposed to rare, drug-resistant strain of HIV after a sexual partner neglected their antiretroviral treatment